Paper279397
Phase 1 clinical investigation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (NSC 249992), a new acridine derivative.
Legha SS and 6 others. Cancer Res, 1978. Cited by 129 papers, by iCite.
Cite this record
ConductScience Library. Phase 1 clinical investigation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (NSC 249992), a new acridine derivative. Papers, record 279397. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/279397
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Phase 1 clinical investigation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (NSC 249992), a new acridine derivative.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Acridines | Major topic |
| Neoplasms | Major topic |
| Adenocarcinoma | |
| Adult | |
| Aged | |
| Antineoplastic Agents | |
| Bone Marrow | |
| Drug Administration Schedule | |
| Drug Evaluation | |
| Female | |
| Humans | |
| Injections, Intravenous | |
| Leukemia, Myeloid, Acute | |
| Lung Neoplasms | |
| Male | |
| Melanoma | |
| Middle Aged | |
| Phenylenediamines | |
| Remission, Spontaneous |
Source PubMed
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 129 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 23922861 | Role of minor groove width and hydration pattern on amsacrine interaction with DNA. | PLoS One | 2013 | https://conductscience.org/library/papers/23922861 | PubMed |
| 10789823 | Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention. | Drug Saf | 2000 | https://conductscience.org/library/papers/10789823 | PubMed |
| 7002528 | Cancer chemotherapy: new developments and changing concepts. | Drugs | 1980 | https://conductscience.org/library/papers/7002528 | PubMed |
| 6961970 | Successful treatment of a patient with acute nonlymphoblastic leukemia (ANLL) and anthracycline cardiomyopathy with 4' (9-acridinylamino) methanesulfon-m-anisidide (AMSA). | Cancer Chemother Pharmacol | 1982 | https://conductscience.org/library/papers/6961970 | PubMed |
| 6895696 | A comparison of adriamycin and mAMSA in vitro: cell lethality and SCE studies. | Br J Cancer | 1981 | https://conductscience.org/library/papers/6895696 | PubMed |
| 6895486 | A phase II trial of m-AMSA in head and neck cancer. | Cancer Chemother Pharmacol | 1981 | https://conductscience.org/library/papers/6895486 | PubMed |
| 6895485 | A phase II study of m-AMSA in patients with primary liver cancer. | Cancer Chemother Pharmacol | 1981 | https://conductscience.org/library/papers/6895485 | PubMed |
| 6688382 | Influence of scheduling on therapeutic and toxic effect of AMSA in Lewis lung carcinoma. | Cancer Chemother Pharmacol | 1983 | https://conductscience.org/library/papers/6688382 | PubMed |
| 6583026 | Human tissue distribution of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (NSC 141549, AMSA). | Cancer Chemother Pharmacol | 1984 | https://conductscience.org/library/papers/6583026 | PubMed |
| 3621451 | Dose-dependent skin ulcers in mice treated with DNA binding antitumor antibiotics. | Cancer Chemother Pharmacol | 1987 | https://conductscience.org/library/papers/3621451 | PubMed |
| 3568274 | Amsacrine treatment of patients with supraventricular arrhythmias and acute leukemia. | Cancer Chemother Pharmacol | 1987 | https://conductscience.org/library/papers/3568274 | PubMed |
| 3186443 | Cooperative binding of m-AMSA to nucleic acids. | Nucleic Acids Res | 1988 | https://conductscience.org/library/papers/3186443 | PubMed |
| 2602146 | Thermodynamics of the interactions of m-AMSA and o-AMSA with nucleic acids: influence of ionic strength and DNA base composition. | Nucleic Acids Res | 1989 | https://conductscience.org/library/papers/2602146 | PubMed |
| 393427 | m-AMSA and PALA: two new agents in cancer chemotherapy. | Cancer Chemother Pharmacol | 1979 | https://conductscience.org/library/papers/393427 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/279397
GET https://conductscience.org/api/papers/v1/279397/authors